123 related articles for article (PubMed ID: 10919640)
21. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
Zhang D; Cao D; Russell R; Pizzorno G
Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
[TBL] [Abstract][Full Text] [Related]
22. Cloning and characterization of a new type of mouse chemokine.
Rossi DL; Hardiman G; Copeland NG; Gilbert DJ; Jenkins N; Zlotnik A; Bazan JF
Genomics; 1998 Jan; 47(2):163-70. PubMed ID: 9479488
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
24. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.
Xu Q; Wang S; Jiang X; Zhao Y; Gao M; Zhang Y; Wang X; Tano K; Kanehara M; Zhang W; Ishida T
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):624-31. PubMed ID: 17581219
[TBL] [Abstract][Full Text] [Related]
26. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
[TBL] [Abstract][Full Text] [Related]
27. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
28. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
Liang SX; Richardson DR
Carcinogenesis; 2003 Oct; 24(10):1601-14. PubMed ID: 12869419
[TBL] [Abstract][Full Text] [Related]
29. [Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene].
Li J; Liu Y; Dai JZ; Xu DP; Zhang LX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):26-9. PubMed ID: 16642213
[TBL] [Abstract][Full Text] [Related]
30. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells.
Kanazawa N; Nakamura T; Tashiro K; Muramatsu M; Morita K; Yoneda K; Inaba K; Imamura S; Honjo T
Eur J Immunol; 1999 Jun; 29(6):1925-32. PubMed ID: 10382755
[TBL] [Abstract][Full Text] [Related]
31. Wig-1, a new p53-induced gene encoding a zinc finger protein.
Varmeh-Ziaie S; Okan I; Wang Y; Magnusson KP; Warthoe P; Strauss M; Wiman KG
Oncogene; 1997 Nov; 15(22):2699-704. PubMed ID: 9400996
[TBL] [Abstract][Full Text] [Related]
32. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system.
Okamura S; Ng CC; Koyama K; Takei Y; Arakawa H; Monden M; Nakamura Y
Oncol Res; 1999; 11(6):281-5. PubMed ID: 10691030
[TBL] [Abstract][Full Text] [Related]
33. Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
Zhang W; Shay JW; Deisseroth A
Cancer Res; 1993 Oct; 53(20):4772-5. PubMed ID: 8402659
[TBL] [Abstract][Full Text] [Related]
34. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence.
Purdie KJ; Pennington J; Proby CM; Khalaf S; de Villiers EM; Leigh IM; Storey A
EMBO J; 1999 Oct; 18(19):5359-69. PubMed ID: 10508168
[TBL] [Abstract][Full Text] [Related]
35. Targeting gene expression to tumor cells with loss of wild-type p53 function.
Zhu J; Gao B; Zhao J; Balmain A
Cancer Gene Ther; 2000 Jan; 7(1):4-12. PubMed ID: 10678350
[TBL] [Abstract][Full Text] [Related]
36. wt p53 dependent expression of a membrane-associated isoform of adenylate kinase.
Collavin L; Lazarevic D; Utrera R; Marzinotto S; Monte M; Schneider C
Oncogene; 1999 Oct; 18(43):5879-88. PubMed ID: 10557075
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells.
Imaizumi T; Matsumiya T; Fujimoto K; Okamoto K; Cui X; Ohtaki U; Hidemi ; Yoshida ; Satoh K
Tohoku J Exp Med; 2000 Oct; 192(2):127-39. PubMed ID: 11211312
[TBL] [Abstract][Full Text] [Related]
38. Use of transcription reporters with novel p53 binding sites to target tumour cells expressing endogenous or virally transduced p53 mutants with altered sequence-specificity.
Gagnebin J; Kovar H; Kajava AV; Estreicher A; Jug G; Monnier P; Iggo R
Oncogene; 1998 Feb; 16(5):685-90. PubMed ID: 9482117
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
Li B; Lee MY
J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
[TBL] [Abstract][Full Text] [Related]
40. Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system.
Takei Y; Ishikawa S; Tokino T; Muto T; Nakamura Y
Genes Chromosomes Cancer; 1998 Sep; 23(1):1-9. PubMed ID: 9713990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
